Edgewise Therapeutics Inc

NASDAQ:EWTX   3:59:51 PM EDT
5.66
-0.69 (-10.87%)
Earnings Announcements

Edgewise Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/11/2022 12:06 GMT
Edgewise Therapeutics Inc (EWTX) - Edgewise Therapeutics Reports First Quarter 2022 Financial Results.
Cash, Cash Equivalents and Marketable Securities of $265.8 Million As of March 31, 2022.
Qtrly Net Loss per Share for Q1 of 2022 Was $0.30.
Q1 Earnings per Share View $-0.28 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.